TY - JOUR
T1 - Adding Pharmacist-Led Home Blood Pressure Telemonitoring to Usual Care for Blood Pressure Control
T2 - A Systematic Review and Meta-Analysis
AU - Baral, Nischit
AU - Volgman, Annabelle Santos
AU - Seri, Amith
AU - Chelikani, Vijaya
AU - Isa, Sakiru
AU - Javvadi, Sri L.P.
AU - Paul, Timir K.
AU - Mitchell, Joshua D.
N1 - Publisher Copyright:
© 2023 The Author(s)
PY - 2023/9/15
Y1 - 2023/9/15
N2 - Health systems have been quickly adopting telemedicine throughout the United States, especially since the onset of the COVID-19 pandemic. However, there are limited data on whether adding pharmacist-led home blood pressure (BP) telemonitoring to office-based usual care improves BP. We searched PubMed/MEDLINE and Embase for randomized controlled trials from January 2000 until April 2022, comparing studies on pharmacist-led home BP telemonitoring with usual care. Six randomized controlled trials, including 1,550 participants, satisfied the inclusion criteria. There were 774 participants in the pharmacist-led telemonitoring group and 776 in the usual care group. The addition of pharmacist-led telemonitoring to usual care was associated with a significant decrease in systolic BP (mean difference −8.09, 95% confidence interval −11.15 to −5.04, p <0.001, I2 = 72%) and diastolic BP (mean difference −4.19, 95% confidence interval −5.58 to −2.81, p <0.001, I2 = 42%) compared with usual care. In conclusion, this meta-analysis showed that adding pharmacist-led home BP telemonitoring to usual care achieves better BP control than usual care alone.
AB - Health systems have been quickly adopting telemedicine throughout the United States, especially since the onset of the COVID-19 pandemic. However, there are limited data on whether adding pharmacist-led home blood pressure (BP) telemonitoring to office-based usual care improves BP. We searched PubMed/MEDLINE and Embase for randomized controlled trials from January 2000 until April 2022, comparing studies on pharmacist-led home BP telemonitoring with usual care. Six randomized controlled trials, including 1,550 participants, satisfied the inclusion criteria. There were 774 participants in the pharmacist-led telemonitoring group and 776 in the usual care group. The addition of pharmacist-led telemonitoring to usual care was associated with a significant decrease in systolic BP (mean difference −8.09, 95% confidence interval −11.15 to −5.04, p <0.001, I2 = 72%) and diastolic BP (mean difference −4.19, 95% confidence interval −5.58 to −2.81, p <0.001, I2 = 42%) compared with usual care. In conclusion, this meta-analysis showed that adding pharmacist-led home BP telemonitoring to usual care achieves better BP control than usual care alone.
UR - http://www.scopus.com/inward/record.url?scp=85165641278&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2023.06.109
DO - 10.1016/j.amjcard.2023.06.109
M3 - Article
C2 - 37499595
AN - SCOPUS:85165641278
SN - 0002-9149
VL - 203
SP - 161
EP - 168
JO - American Journal of Cardiology
JF - American Journal of Cardiology
ER -